Registration for a live webinar on 'Chronic inflammation, immune cell trafficking and anti-trafficking agents' is now open.See webinar details
Prof. Paul L. DeAngelis University of Oklahoma, USA, Caisson Biotech LLC, USA and Hyalose LLC, USA1 Talk
Paul L. DeAngelis, PhD, is a glycobiology researcher exploring and harnessing glycosaminoglycan [GAG] biosynthesis. He received his undergraduate training at Harvard University and his PhD from the University of California, Irvine. Since 1981glycobiology has been his research focus, from 1998-2004 his academic team at University of Oklahoma Health Sciences Center... read morediscovered a variety of enzymes that polymerize GAG polymers. Between 2000-2009 he started four biotech companies in commercializing recombinant GAG products. Paul's current interest is creating GAG-based therapeutics using chemoenzymatic synthesis.